The 2′-5′ oligoadenylate synthetases (OAS) are interferon-induced antiviral enzymes that recognize virally produced dsRNA and initiate RNA destabilization through activation of RNase L within infected cells. However, recent evidence points toward several RNase L–independent pathways, through which members of the OAS family can exert antiviral activity. The crystal structure of OAS led to a novel insight into the catalytic mechanism, and revealed a remarkable similarity between OAS, Polyadenosine polymerase, and the class I CCA-adding enzyme from Archeoglobus fulgidus. This, combined with a variety of bioinformatic data, leads to the definition of a superfamily of template independent polymerases and proved that the OAS family are ancient proteins, which probably arose as early as the beginning of metazoan evolution.
Get full access to this article
View all access options for this article.
References
1.
BaglioniC, MinksMA, MaroneyPA. 1978. Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A. Nature, 273:684–687.
2.
BeeseLS, SteitzTA. 1991. Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO J, 10:25–33.
3.
BenechP, MoryY, RevelM, ChebathJ. 1985. Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J, 4:2249–2256.
4.
BrehinAC, CasademontI, FrenkielMP, JulierC, SakuntabhaiA, DespresP. 2009. The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus. Virology, 384:216–222.
5.
CayleyPJ, WhiteRF, AntoniwJF, WalesbyNJ, KerrIM. 1982. Distribution of the ppp(A2'p)nA-binding protein and interferon-related enzymes in animals, plants, and lower organisms. Biochem Biophys Res Commun, 108:1243–1250.
6.
ChebathJ, BenechP, RevelM, VigneronM. 1987. Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection. Nature, 330:587–588.
7.
ChoHD, VerlindeCL, WeinerAM. 2005. Archaeal CCA-adding enzymes: central role of a highly conserved beta-turn motif in RNA polymerization without translocation. J Biol Chem, 280:9555–9566.
8.
ClemensMJ, WilliamsBR. 1978. Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell, 13:565–572.
9.
DelarueM, PochO, TordoN, MorasD, ArgosP. 1990. An attempt to unify the structure of polymerases. Protein Eng, 3:461–467.
10.
DesaiSY, SenGC. 1997. Effects of varying lengths of double-stranded RNA on binding and activation of 2'-5'-oligoadenylate synthetase. J Interferon Cytokine Res, 17:531–536.
11.
DongB, SilvermanRH. 1997. A bipartite model of 2-5A-dependent RNase L. J Biol Chem, 272:22236–22242.
12.
EskildsenS, HartmannR, KjeldgaardNO, JustesenJ. 2002. Gene structure of the murine 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci, 59:1212–1222.
13.
EskildsenS, JustesenJ, SchierupMH, HartmannR. 2003. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res, 31:3166–3173.
14.
GhoshA, SarkarSN, GuoW, BandyopadhyayS, SenGC. 1997. Enzymatic activity of 2'-5'-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein. J Biol Chem, 272:33220–33226.
15.
GhoshA, SarkarSN, SenGC. 2000. Cell growth regulatory and antiviral effects of the P69 isozyme of 2–5 (A) synthetase. Virology, 266:319–328.
16.
GhoshSK, KusariJ, BandyopadhyaySK, SamantaH, KumarR, SenGC. 1991. Cloning, sequencing, and expression of two murine 2'-5'-oligoadenylate synthetases. Structure-function relationships. J Biol Chem, 266:15293–15299.
17.
HamanoE, HijikataM, ItoyamaS, QuyT, PhiNC, LongHT, HaLD, BanVV, MatsushitaI, YanaiHand others2005. Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun, 329:1234–1239.
18.
HartmannR, JustesenJ, SarkarSN, SenGC, YeeVC. 2003. Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase. Mol Cell, 12:1173–1185.
19.
HartmannR, NorbyPL, MartensenPM, JorgensenP, JamesMC, JacobsenC, MoestrupSK, ClemensMJ, JustesenJ. 1998a. Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J Biol Chem, 273:3236–3246.
20.
HartmannR, OlsenHS, WidderS, JorgensenR, JustesenJ. 1998b. p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family. Nucleic Acids Res, 26:4121–4128.
21.
HartmannR, WalkoG, JustesenJ. 2001. Inhibition of 2'-5' oligoadenylate synthetase by divalent metal ions. FEBS Lett, 507:54–58.
22.
HeJ, FengD, de VlasSJ, WangH, FontanetA, ZhangP, PlancoulaineS, TangF, ZhanL, YangHand others2006. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis, 6:106.
23.
HolmL, SanderC. 1995. DNA polymerase beta belongs to an ancient nucleotidyltransferase superfamily. Trends Biochem Sci, 20:345–347.
24.
HovnanianA, RebouillatD, MatteiMG, LevyER, MarieI, MonacoAP, HovanessianAG. 1998. The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics, 52:267–277.
25.
HovanessianAG, BrownRE, KerrIM. 1977. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature, 268:537–540.
26.
JustesenJ, HartmannR, KjeldgaardNO. 2000. Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci, 57:1593–1612.
27.
Kajaste-RudnitskiA, MashimoT, FrenkielMP, GuenetJL, LucasM, DespresP. 2006. The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J Biol Chem, 281:4624–4637.
28.
KakutaS, ShibataS, IwakuraY. 2002. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family. J Interferon Cytokine Res, 22:981–993.
29.
KerrIM, BrownRE, HovanessianAG. 1977. Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature, 268:540–542.
30.
KjaerKH, PoulsenJB, ReintammT, SabyE, MartensenPM, KelveM, JustesenJ. 2009. Evolution of the 2'-5'-oligoadenylate synthetase family in eukaryotes and bacteria. J Mol Evol, 69:612–624.
31.
KnappS, YeeLJ, FrodshamAJ, HennigBJ, HellierS, ZhangL, WrightM, ChiaramonteM, GravesM, ThomasHCand others2003. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun, 4:411–419.
32.
LimJK, LiscoA, McDermottDH, HuynhL, WardJM, JohnsonB, JohnsonH, PapeJ, FosterGA, KrysztofDand others2009. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog, 5:e1000321.
33.
LinRJ, YuHP, ChangBL, TangWC, LiaoCL, LinYL. 2009. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection. J Immunol, 183:8035–8043.
34.
MarieI, HovanessianAG. 1992. The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J Biol Chem, 267:9933–9939.
35.
MarieI, RebouillatD, HovanessianAG. 1999. The expression of both domains of the 69/71 kDa 2',5' oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur J Biochem, 262:155–165.
36.
MarieI, SvabJ, RobertN, GalabruJ, HovanessianAG. 1990. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J Biol Chem, 265:18601–18607.
37.
MarquesJ, AnwarJ, Eskildsen-LarsenS, RebouillatD, PaludanSR, SenG, WilliamsBR, HartmannR. 2008. The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain. J Gen Virol, 89:2767–2772.
38.
MartinG, JenoP, KellerW. 1999. Mapping of ATP binding regions in poly(A) polymerases by photoaffinity labeling and by mutational analysis identifies a domain conserved in many nucleotidyltransferases. Protein Sci, 8:2380–2391.
MashimoT, LucasM, Simon-ChazottesD, FrenkielMP, MontagutelliX, CeccaldiPE, DeubelV, GuenetJL, DespresP. 2002. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA, 99:11311–11316.
41.
MelchjorsenJ, KristiansenH, ChristiansenR, RintahakaJ, MatikainenS, PaludanSR, HartmannR. 2009. Differential regulation of the OASL and OAS1 genes in response to viral infections. J Interferon Cytokine Res, 29:199–207.
42.
PerelyginAA, ScherbikSV, ZhulinIB, StockmanBM, LiY, BrintonMA. 2002. Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA, 99:9322–9327.
43.
PerelyginAA, ZharkikhAA, ScherbikSV, BrintonMA. 2006. The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla. J Mol Evol, 63:562–576.
44.
RebouillatD, HovnanianA, MarieI, HovanessianAG. 1999. The 100-kDa 2',5'-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2'p5'A molecules is composed of three homologous domains. J Biol Chem, 274:1557–1565.
45.
RebouillatD, MarieI, HovanessianAG. 1998. Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2'-5' oligoadenylate synthetase. Eur J Biochem, 257:319–330.
46.
RobertsWK, HovanessianA, BrownRE, ClemensMJ, KerrIM. 1976. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature, 264:477–480.
47.
SarkarSN, BandyopadhyayS, GhoshA, SenGC. 1999a. Enzymatic characteristics of recombinant medium isozyme of 2'-5' oligoadenylate synthetase. J Biol Chem, 274:1848–1855.
48.
SarkarSN, GhoshA, WangHW, SungSS, SenGC. 1999b. The nature of the catalytic domain of 2'-5'-oligoadenylate synthetases. J Biol Chem, 274:25535–25542.
49.
SarkarSN, PalS, SenGC. 2002. Crisscross enzymatic reaction between the two molecules in the active dimeric P69 form of the 2'-5' oligodenylate synthetase. J Biol Chem, 277:44760–44764.
50.
ScherbikSV, KluetzmanK, PerelyginAA, BrintonMA. 2007. Knock-in of the Oas1b(r) allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype. Virology, 368:232–237.
51.
SilvermanRH. 2007. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol, 81:12720–12729.
52.
SteitzTA. 1999. DNA polymerases: structural diversity and common mechanisms. J Biol Chem, 274:17395–17398.
53.
SteitzTA, SmerdonSJ, JagerJ, JoyceCM. 1994. A unified polymerase mechanism for nonhomologous DNA and RNA polymerases. Science, 266:2022–2025.
54.
TorralbaS, SojatJ, HartmannR. 2008. 2'-5' oligoadenylate synthetase shares active site architecture with the archaeal CCA-adding enzyme. Cell Mol Life Sci, 65:2613–2620.
55.
WatheletM, MoutschenS, CravadorA, DeWitL, DefilippiP, HuezG, ContentJ. 1986. Full-length sequence and expression of the 42 kDa 2-5A synthetase induced by human interferon. FEBS Lett, 196:113–120.
56.
WiensM, KuusksaluA, KelveM, MullerWE. 1999. Origin of the interferon-inducible (2'-5')oligoadenylate synthetases: cloning of the (2'-5')oligoadenylate synthetase from the marine sponge Geodia cydonium. FEBS Lett, 462:12–18.
57.
YakubI, LillibridgeKM, MoranA, GonzalezOY, BelmontJ, GibbsRA, TweardyDJ. 2005. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis, 192:1741–1748.
58.
ZhouA, ParanjapeJ, BrownTL, NieH, NaikS, DongB, ChangA, TrappB, FairchildR, ColmenaresCand others1997. Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J, 16:6355–6363.
59.
ZilbersteinA, KimchiA, SchmidtA, RevelM. 1978. Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci USA, 75:4734–4738.
